Grown Rogue International (GRUSF) Non-Current Assets (2011 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Non-Current Assets of $41.0 million in Q1 2026, up 896.43% quarter-over-quarter from $4.1 million in Q4 2025, and up 90.58% on a YoY basis from $21.5 million in Q1 2025.
Grown Rogue International (GRUSF) Non-Current Assets (2011 - 2026) Analysis & Trends
Grown Rogue International's Non-Current Assets history runs 15 years deep, the most recent figure standing at $41.0 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 90.58% year-over-year to $41.0 million; the TTM figure through Mar 2026 stood at $48078551086.7 billion (up 67174393519007.25% YoY), while the FY2025 annual figure was $4.1 million, up 10.16% from the prior year.
- Non-Current Assets was $41.0 million for Q1 2026 at Grown Rogue International, up from $4.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $48078527000.0 billion in Q2 2025 to a low of $3.7 million in Q4 2024.
- Historically, Non-Current Assets has averaged $3698350083.6 billion across 5 years, with a median of $15.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets slumped 63.7% in 2024, then soared 320009855697765.06% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $3.7 million in 2022, then soared by 174.93% to $10.3 million in 2023, then plunged by 63.7% to $3.7 million in 2024, then increased by 10.16% to $4.1 million in 2025, then soared by 896.43% to $41.0 million in 2026.
- The last three Non-Current Assets figures came in at $41.0 million (Q1 2026), $4.1 million (Q4 2025), and $24086.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 40.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.99 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Sep 30, 2025 | 24,086.70 Bn |
| Jun 30, 2025 | 48,078,526,999.97 Bn |
| Mar 31, 2025 | 21.51 Mn |
| Dec 31, 2024 | 3.73 Mn |
| Sep 30, 2024 | 16.38 Mn |
| Jun 30, 2024 | 15.02 Mn |
| Mar 31, 2024 | 18.66 Mn |
| Dec 31, 2023 | 10.29 Mn |
| Oct 31, 2023 | 4.02 Mn |
| Jan 31, 2023 | 8.61 Mn |
| Oct 31, 2022 | 3.74 Mn |
| Oct 31, 2021 | 4.02 Mn |
| Apr 30, 2021 | 5.05 Mn |
| Jan 31, 2021 | 3.00 Mn |
| Oct 31, 2020 | 603,895.00 |
| Jul 31, 2020 | 2.13 Mn |
| Apr 30, 2020 | 2.19 Mn |
| Jan 31, 2020 | 1.49 Mn |